Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Elke Kahler"'
Autor:
Tetiana Tatarchuk, John C. Stevenson, Qi Yu, Elke Kahler, Marcelo Graziano Custodio, Mulan Ren, Rossella E. Nappi, Viktoriya Karpova, Tommaso Simoncini
Publikováno v:
Gynecological Endocrinology, Vol 40, Iss 1 (2024)
Objective: To assess the safety and tolerability of ultra-low dose estradiol and dydrogesterone (E0.5 mg/D2.5 mg) among postmenopausal women. Methods: This pooled analysis of data from three clinical studies assessed the effects of continuous combine
Externí odkaz:
https://doaj.org/article/2a693e7feb49414b83fe22b7a3c445aa
Autor:
Georg Griesinger, Christophe Blockeel, Elke Kahler, Claire Pexman-Fieth, Jan I Olofsson, Stefan Driessen, Herman Tournaye
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0241044 (2020)
The aim of this systematic review and meta-analysis was to conduct a comprehensive assessment of the evidence on the efficacy and safety of oral dydrogesterone versus micronized vaginal progesterone (MVP) for luteal phase support. Embase and MEDLINE
Externí odkaz:
https://doaj.org/article/21c178fccef2420a9d11a1a2dc6ae70c
Autor:
Zeqi Zheng, Hong Mao, Yong Huo, Tingbo Jiang, Elke Kahler, Qiuling Zhang, Litong Qi, Zhaohui Pei, Dmitri Kazei
Publikováno v:
Vascular Health and Risk Management
Litong Qi,1 Qiuling Zhang,2 Zeqi Zheng,3 Zhaohui Pei,4 Hong Mao,5 Tingbo Jiang,6 Dmitri Kazei,7 Elke Kahler,8 Yong Huo1 1Peking University First Hospital, Beijing, 100034, Peopleâs Republic of China; 2The Affiliated Hospital of Hangzhou Normal U
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f6058a44dc32d8f2534eb80111b85d0
https://pubmed.ncbi.nlm.nih.gov/34552329
https://pubmed.ncbi.nlm.nih.gov/34552329
Autor:
Hanwang Zhang, Elke Kahler, Claire Pexman-Fieth, Jan I. Olofsson, Zi-Jiang Chen, Fei Gong, Wei Wang, Xiaoyan Liang, Herman Tournaye, Georg Griesinger, Dongzi Yang, Yingpu Sun
Publikováno v:
Gynecological Endocrinology. 36:175-183
Lotus II, a randomized, open-label, multicenter, international study compared the efficacy and safety of oral dydrogesterone versus micronized vaginal progesterone (MVP) gel for luteal support in IVF. A prespecified subgroup analysis was performed on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba43c84f8944f0be6bdd16336ede03c2
https://doi.org/10.1080/09513590.2019.1645110
https://doi.org/10.1080/09513590.2019.1645110
Autor:
Claire Pexman-Fieth, Stefan Driessen, Georg Griesinger, Christophe Blockeel, Elke Kahler, Jan I. Olofsson, Herman Tournaye
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 11, p e0241044 (2020)
PLoS ONE, Vol 15, Iss 11, p e0241044 (2020)
The aim of this systematic review and meta-analysis was to conduct a comprehensive assessment of the evidence on the efficacy and safety of oral dydrogesterone versus micronized vaginal progesterone (MVP) for luteal phase support. Embase and MEDLINE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a73dbd13983ea2bf5da90505e5ffd2f4
https://hdl.handle.net/20.500.14017/62b1497d-1b34-455e-a9b6-99a94920b2f1
https://hdl.handle.net/20.500.14017/62b1497d-1b34-455e-a9b6-99a94920b2f1
Autor:
Dong-Zi, Yang, Georg, Griesinger, Wei, Wang, Fei, Gong, Xiaoyan, Liang, Hanwang, Zhang, Yingpu, Sun, Elke, Kahler, Claire, Pexman-Fieth, Jan I, Olofsson, Herman, Tournaye, Zi-Jiang, Chen
Publikováno v:
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 36(2)
Lotus II, a randomized, open-label, multicenter, international study compared the efficacy and safety of oral dydrogesterone versus micronized vaginal progesterone (MVP) gel for luteal support in IVF. A prespecified subgroup analysis was performed on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::444e12be6d726569ef7a235991c061ed
https://pubmed.ncbi.nlm.nih.gov/31397179
https://pubmed.ncbi.nlm.nih.gov/31397179
Autor:
Georg Griesinger, Elke Kahler, Herman Tournaye, Bharati Dhorepatil, Christophe Blockeel, Zi-Jiang Chen, Claire Pexman-Fieth, Ameet Patki, Gennady T. Sukhikh, D. Yang
Publikováno v:
Human Reproduction (Oxford, England)
STUDY QUESTION: Is oral dydrogesterone 30 mg daily non-inferior to 8% micronized vaginal progesterone (MVP) gel 90 mg daily for luteal phase support in IVF? SUMMARY ANSWER: Oral dydrogesterone demonstrated non-inferiority to MVP gel for the presence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0bbbfa6671405ff2a354d2d98dd326b
https://doi.org/10.1093/humrep/dey306
https://doi.org/10.1093/humrep/dey306
Publikováno v:
Human Reproduction (Oxford, England)
STUDY QUESTION: Is oral dydrogesterone 30 mg daily (10 mg three times daily [TID]) non-inferior to micronized vaginal progesterone (MVP) 600 mg daily (200 mg TID) for luteal support in in vitro fertilization (IVF), assessed by the presence of fetal h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9538ac7fc78ea7626e4027cd24dcadb5
https://doi.org/10.1093/humrep/dex023
https://doi.org/10.1093/humrep/dex023
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems. 46(10)
1. The metabolism of dydrogesterone was investigated in human liver cytosol (HLC) and human liver microsomes (HLM). Enzymes involved in dydrogesterone metabolism were identified and their relative contributions were estimated. 2. Dydrogesterone clear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f9cbbab47602a198480a66bfeadfc72
https://pubmed.ncbi.nlm.nih.gov/26796435
https://pubmed.ncbi.nlm.nih.gov/26796435
Publikováno v:
Fertility and Sterility. 110:e90
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::725959c0dd031158d5df61fdff42733b
https://doi.org/10.1016/j.fertnstert.2018.07.271
https://doi.org/10.1016/j.fertnstert.2018.07.271